These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11931622)

  • 21. PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization.
    Houslay MD; Adams DR
    Biochem J; 2003 Feb; 370(Pt 1):1-18. PubMed ID: 12444918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of a mutation in phosphodiesterase type 4 that alters both inhibitor activity and nucleotide selectivity.
    Herman SB; Juilfs DM; Fauman EB; Juneau P; Menetski JP
    Mol Pharmacol; 2000 May; 57(5):991-9. PubMed ID: 10779384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conformational difference between PDE4 apoenzyme and holoenzyme.
    Laliberté F; Han Y; Govindarajan A; Giroux A; Liu S; Bobechko B; Lario P; Bartlett A; Gorseth E; Gresser M; Huang Z
    Biochemistry; 2000 May; 39(21):6449-58. PubMed ID: 10828959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structures of the catalytic domain of phosphodiesterase 4B complexed with AMP, 8-Br-AMP, and rolipram.
    Xu RX; Rocque WJ; Lambert MH; Vanderwall DE; Luther MA; Nolte RT
    J Mol Biol; 2004 Mar; 337(2):355-65. PubMed ID: 15003452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a catalytic ligand bridging metal ions in phosphodiesterases 4 and 5 by molecular dynamics simulations and hybrid quantum mechanical/molecular mechanical calculations.
    Xiong Y; Lu HT; Li Y; Yang GF; Zhan CG
    Biophys J; 2006 Sep; 91(5):1858-67. PubMed ID: 16912214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A-mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1).
    MacKenzie SJ; Baillie GS; McPhee I; MacKenzie C; Seamons R; McSorley T; Millen J; Beard MB; van Heeke G; Houslay MD
    Br J Pharmacol; 2002 Jun; 136(3):421-33. PubMed ID: 12023945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. cAMP-Specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling.
    Houslay MD; Baillie GS; Maurice DH
    Circ Res; 2007 Apr; 100(7):950-66. PubMed ID: 17431197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term regulation of PDE4 activity.
    Manganiello V
    Br J Pharmacol; 2002 Jun; 136(3):339-40. PubMed ID: 12023934
    [No Abstract]   [Full Text] [Related]  

  • 29. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant.
    Erdogan S; Houslay MD
    Biochem J; 1997 Jan; 321 ( Pt 1)(Pt 1):165-75. PubMed ID: 9003416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atomic structure of PDE4: insights into phosphodiesterase mechanism and specificity.
    Xu RX; Hassell AM; Vanderwall D; Lambert MH; Holmes WD; Luther MA; Rocque WJ; Milburn MV; Zhao Y; Ke H; Nolte RT
    Science; 2000 Jun; 288(5472):1822-5. PubMed ID: 10846163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation of rat liver microsomal cGMP-inhibited cAMP phosphodiesterase (PDE III) by phospholipase C and D.
    Carpenedo F; Floreani M
    Biochem Biophys Res Commun; 1993 Jan; 190(2):609-15. PubMed ID: 8381282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "cAMP-specific" phosphodiesterase contributes to cGMP degradation in cerebellar cells exposed to nitric oxide.
    Bellamy TC; Garthwaite J
    Mol Pharmacol; 2001 Jan; 59(1):54-61. PubMed ID: 11125024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rolipram inhibition of phosphodiesterase-4 activation.
    DiSanto ME; Heaslip RJ
    Eur J Pharmacol; 1995 Jul; 290(2):169-72. PubMed ID: 8575533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphodiesterase 4 in macrophages: relationship between cAMP accumulation, suppression of cAMP hydrolysis and inhibition of [3H]R-(-)-rolipram binding by selective inhibitors.
    Kelly JJ; Barnes PJ; Giembycz MA
    Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):425-36. PubMed ID: 8809029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The unique N-terminal domain of the cAMP phosphodiesterase PDE4D4 allows for interaction with specific SH3 domains.
    Beard MB; O'Connell JC; Bolger GB; Houslay MD
    FEBS Lett; 1999 Oct; 460(1):173-7. PubMed ID: 10571082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between phosphodiesterases in the regulation of the cardiac β-adrenergic pathway.
    Zhao CY; Greenstein JL; Winslow RL
    J Mol Cell Cardiol; 2015 Nov; 88():29-38. PubMed ID: 26388264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular smooth muscle cell phosphodiesterase (PDE) 3 and PDE4 activities and levels are regulated by cyclic AMP in vivo.
    Tilley DG; Maurice DH
    Mol Pharmacol; 2002 Sep; 62(3):497-506. PubMed ID: 12181425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and characterization of deletion recombinants of two cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE-3).
    He R; Komas N; Ekholm D; Murata T; Taira M; Hockman S; Degerman E; Manganiello VC
    Cell Biochem Biophys; 1998; 29(1-2):89-111. PubMed ID: 9631240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of 3',5' cyclic nucleotide phosphodiesterase activity in Y79 retinoblastoma cells: absence of functional PDE6.
    White JB; Thompson WJ; Pittler SJ
    Mol Vis; 2004 Oct; 10():738-49. PubMed ID: 15480303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of a novel cAMP-binding, cAMP-specific cyclic nucleotide phosphodiesterase (TcrPDEB1) from Trypanosoma cruzi.
    Díaz-Benjumea R; Laxman S; Hinds TR; Beavo JA; Rascón A
    Biochem J; 2006 Oct; 399(2):305-14. PubMed ID: 16776650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.